Genfit SA ADR GNFTY
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 50.03M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 6.04
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements to fund the further development of its products. It has one segment, the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 192
- Website
- https://www.genfit.com
Valuation
|
Metric
|
GNFTY
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 6.04 |
Price/Cash Flow | — |
Price/Earnings
GNFTY
Financial Strength
|
Metric
|
GNFTY
|
|---|---|
Quick Ratio | 1.55 |
Current Ratio | 1.58 |
Interest Coverage | −1,196.00 |
Quick Ratio
GNFTY
Profitability
|
Metric
|
GNFTY
|
|---|---|
Return on Assets (Normalized) | −28.54% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −34.57% |
Return on Assets
GNFTY
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|S%?M#> | LOCK|QBwY@ | $128B | |||
| Moderna Inc
MRNA
| LOCK|^S>l&NL | LOCK|F@M | $79B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|X%%%Fl? | LOCK|>V@j | $76B | |||
| argenx SE ADR
ARGX
| LOCK|MH>&#$W | LOCK|<V | $50B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|z%V$#$ | LOCK|!%d | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|GnF^Pg | LOCK|$c?T | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|VhGF%wq | LOCK|$$V@ | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|#>!?Bs | LOCK|Q%G | $23B | |||
| Incyte Corp
INCY
| LOCK|hB<^@Y | LOCK|%pc | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|Z<Q#b& | LOCK|prY | $14B |
United States